Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID06727604

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease

Led by Immunovant Sciences GmbH · Updated on 2026-05-22

240

Participants Needed

134

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating IMVT-1402 in adults with Graves' disease who remain hyperthyroid despite antithyroid drug treatment. This interventional, randomized, double-blind, placebo-controlled Phase 2b study aims to assess the efficacy, safety, and tolerability of IMVT-1402 compared to placebo. The study's main goal is to see how well IMVT-1402 controls thyroid hormone levels and reduces the need for antithyroid drugs by Week 26. Participants receive IMVT-1402 or placebo through subcutaneous injections once a week. Some groups receive IMVT-1402 for 52 weeks, others receive IMVT-1402 for 26 weeks followed by placebo for 26 weeks, and one group receives placebo for 52 weeks. The study tracks these treatments over a period of up to one year. During the study, participants will have regular blood tests to measure thyroid hormones including T3, FT3, FT4, and thyroid-stimulating hormone (TSH). Researchers will also monitor the dose of antithyroid drugs taken and assess various outcomes like the percentage of participants who achieve normal thyroid levels without antithyroid drugs at different time points. The study includes safety assessments and follows participants for up to 104 weeks to evaluate long-term results.

CONDITIONS

Brief Title

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ability to understand the trial requirements and provide written informed consent
  • Male or female aged 18 years or older
  • Diagnosis of Graves' disease with hyperthyroidism despite antithyroid drug treatment
  • Additional specific criteria as defined in the protocol
Not Eligible

You will not qualify if you...

  • Previous successful treatment with radioactive iodine therapy or total thyroidectomy
  • Having an autoimmune disease other than Graves' disease that requires treatment and poses undue risk
  • Moderate-to-severe active thyroid eye disease expected to require immediate surgical intervention or planned corrective surgery, irradiation, or medical therapy during the study
  • Additional exclusion criteria as defined in the protocol

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 52 weeks

Participants receive weekly subcutaneous injections of IMVT-1402 or placebo for up to 52 weeks as part of the study treatment.

Weekly visits for up to 52 weeks

Follow-up

Duration - Up to 26 weeks after treatment

Participants are monitored for efficacy and safety outcomes after completing treatment.

Visits as scheduled for assessment up to Week 78 and Week 104

Trial Site Locations

Total: 134 locations

1

Site Number - 1032

Phoenix, Arizona, United States, 85006

Withdrawn

2

Site Number - 1036

Phoenix, Arizona, United States, 85015

Actively Recruiting

3

Site Number - 1061

Huntington Beach, California, United States, 92647

Actively Recruiting

4

Site Number - 1001

Los Angeles, California, United States, 90033

Actively Recruiting

5

Site Number - 1047

Los Angeles, California, United States, 90095

Actively Recruiting

6

Site Number - 1062

Orange, California, United States, 92868

Actively Recruiting

7

Site Number - 1046

Sacramento, California, United States, 95816

Actively Recruiting

8

Site Number - 1034

San Francisco, California, United States, 94143

Actively Recruiting

9

Site Number - 1035

Santa Clarita, California, United States, 91321

Withdrawn

10

Site Number - 1005

Torrance, California, United States, 90502

Actively Recruiting

11

Site Number - 1006

Walnut Creek, California, United States, 94598

Withdrawn

12

Site Number - 1013

Englewood, Colorado, United States, 80113

Actively Recruiting

13

Site Number - 1010

Newark, Delaware, United States, 19713

Actively Recruiting

14

Site Number - 1040

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

15

Site Number - 1029

Clearwater, Florida, United States, 33756

Actively Recruiting

16

Site Number - 1055

Jacksonville, Florida, United States, 32204-1177

Actively Recruiting

17

Site Number - 1056

Jacksonville, Florida, United States, 32216

Actively Recruiting

18

Site Number - 1028

Miami, Florida, United States, 33136

Actively Recruiting

19

Site Number - 1065

Miami, Florida, United States, 33186

Actively Recruiting

20

Site Number - 1064

Ocoee, Florida, United States, 34761

Actively Recruiting

21

Site Number - 1011

Orlando, Florida, United States, 32819

Actively Recruiting

22

Site Number - 1016

Port Charlotte, Florida, United States, 33952

Actively Recruiting

23

Site Number - 1012

West Palm Beach, Florida, United States, 33401

Actively Recruiting

24

Site Number - 1038

Atlanta, Georgia, United States, 30318

Actively Recruiting

25

Site Number - 1053

Macon, Georgia, United States, 31210

Actively Recruiting

26

Site Number - 1020

Stockbridge, Georgia, United States, 30281

Actively Recruiting

27

Site Number - 1027

Indianapolis, Indiana, United States, 46202

Actively Recruiting

28

Site Number - 1041

Kansas City, Kansas, United States, 66210

Actively Recruiting

29

Site Number - 1045

Bowling Green, Kentucky, United States, 42101

Actively Recruiting

30

Site Number - 1054

Florence, Kentucky, United States, 41042

Actively Recruiting

31

Site Number - 1063

Metairie, Louisiana, United States, 70006

Actively Recruiting

32

Site Number - 1022

New Orleans, Louisiana, United States, 70112

Actively Recruiting

33

Site Number - 1048

Shreveport, Louisiana, United States, 71103

Actively Recruiting

34

Site Number - 1023

Baltimore, Maryland, United States, 21287

Actively Recruiting

35

Site Number - 1026

Boston, Massachusetts, United States, 02114

Actively Recruiting

36

Site Number - 1018

Farmington Hills, Michigan, United States, 48334

Actively Recruiting

37

Site Number - 1069

Flint, Michigan, United States, 48532

Actively Recruiting

38

Site Number - 1008

Rochester, Minnesota, United States, 55905

Actively Recruiting

39

Site Number - 1068

Gulfport, Mississippi, United States, 39501

Actively Recruiting

40

Site Number - 1017

Omaha, Nebraska, United States, 68105

Actively Recruiting

41

Site Number - 1007

Las Vegas, Nevada, United States, 89148

Actively Recruiting

42

Site Number - 1050

Monroe, New York, United States, 10950

Actively Recruiting

43

Site Number - 1051

Asheville, North Carolina, United States, 28803

Actively Recruiting

44

Site Number - 1060

Wilmington, North Carolina, United States, 28401

Actively Recruiting

45

Site Number - 1057

Canton, Ohio, United States, 44718

Actively Recruiting

46

Site Number - 1003

Portland, Oregon, United States, 97035

Actively Recruiting

47

Site Number - 1033

Philadelphia, Pennsylvania, United States, 19140

Withdrawn

48

Site Number - 1043

Pottstown, Pennsylvania, United States, 19464

Actively Recruiting

49

Site Number - 1015

Summerville, South Carolina, United States, 29485

Actively Recruiting

50

Site Number - 1042

Chattanooga, Tennessee, United States, 37421

Actively Recruiting

51

Site Number - 1066

Nashville, Tennessee, United States, 37203

Actively Recruiting

52

Site Number - 1049

Nashville, Tennessee, United States, 37212

Actively Recruiting

53

Site Number - 1002

Austin, Texas, United States, 78731

Actively Recruiting

54

Site Number - 1067

Bellaire, Texas, United States, 77401

Actively Recruiting

55

Site Number - 1019

Dallas, Texas, United States, 75208

Actively Recruiting

56

Site Number - 1031

Dallas, Texas, United States, 75231

Withdrawn

57

Site Number - 1071

Houston, Texas, United States, 77089

Actively Recruiting

58

Site Number - 1025

Houston, Texas, United States, 77095

Withdrawn

59

Site Number - 1004

Mesquite, Texas, United States, 75149

Actively Recruiting

60

Site Number - 1009

Round Rock, Texas, United States, 78681

Actively Recruiting

61

Site Number - 1014

San Antonio, Texas, United States, 78215

Actively Recruiting

62

Site Number - 1052

San Antonio, Texas, United States, 78240

Actively Recruiting

63

Site Number - 1030

Salt Lake City, Utah, United States, 84108

Actively Recruiting

64

Site Number - 1070

Sandy City, Utah, United States, 84093

Actively Recruiting

65

Site Number - 5303

Antwerp, Belgium, 2820

Actively Recruiting

66

Site Number - 5301

Bruges, Belgium, 80000

Actively Recruiting

67

Site Number - 5302

Brussels, Belgium, 1070

Actively Recruiting

68

Site Number - 8002

Batumi, Georgia, 6000

Actively Recruiting

69

Site Number - 8007

Batumi, Georgia, 6010

Actively Recruiting

70

Site Number - 8006

Kutaisi, Georgia, 4600

Actively Recruiting

71

Site Number - 8008

Marneuli, Georgia, 3000

Actively Recruiting

72

Site Number - 8009

Tbilisi, Georgia, 0112

Actively Recruiting

73

Site Number - 8004

Tbilisi, Georgia, 0144

Actively Recruiting

74

Site Number - 8005

Tbilisi, Georgia, 0144

Actively Recruiting

75

Site Number - 8001

Tbilisi, Georgia, 0159

Actively Recruiting

76

Site Number - 8003

Tbilisi, Georgia, 0159

Actively Recruiting

77

Site Number - 8011

Tbilisi, Georgia, 0159

Actively Recruiting

78

Site Number - 8010

Tbilisi, Georgia, 0177

Actively Recruiting

79

Site Number - 6505

Dresden, Saxony, Germany, 01307

Actively Recruiting

80

Site Number - 6503

Munich, Germany, 80336

Actively Recruiting

81

Site Number - 6508

Munich, Germany, 81667

Actively Recruiting

82

Site Number - 6502

Schwerin, Germany, 19049

Actively Recruiting

83

Site Number - 6507

Würzburg, Germany, 97080

Actively Recruiting

84

Site Number - 7558

Békéscsaba, Hungary, 5600

Actively Recruiting

85

Site Number - 7554

Budapest, Hungary, 1036

Actively Recruiting

86

Site Number - 7556

Budapest, Hungary, 1083

Actively Recruiting

87

Site Number - 7557

Debrecen, Hungary, 4032

Actively Recruiting

88

Site Number - 7551

Pécs, Hungary, 7623

Actively Recruiting

89

Site Number - 7552

Szeged, Hungary, 6725

Actively Recruiting

90

Site Number - 6004

Bologna, Italy, 40138

Actively Recruiting

91

Site Number - 6012

Cagliari, Italy, 09124

Actively Recruiting

92

Site Number - 6011

Genova, Italy, 16132

Actively Recruiting

93

Site Number - 6002

Milan, Italy, 20122

Actively Recruiting

94

Site Number - 6009

Milan, Italy, 20162

Actively Recruiting

95

Site Number - 6007

Milan, Italy, 20149

Actively Recruiting

96

Site Number - 6010

Naples, Italy, 80131

Actively Recruiting

97

Site Number - 6003

Pisa, Italy, 56124

Actively Recruiting

98

Site Number - 6001

Pisa, Italy, 56126

Actively Recruiting

99

Site Number - 6005

Roma, Italy, 00189

Actively Recruiting

100

Site Number - 6013

Siena, Italy, 53100

Actively Recruiting

101

Site Number - 6008

Varese, Italy, 21100

Actively Recruiting

102

Site Number - 3006

Gliwice, Poland, 44-102

Actively Recruiting

103

Site Number - 3002

Krakow, Poland, 30-074

Actively Recruiting

104

Site Number -3003

Krakow, Poland, 30-688

Actively Recruiting

105

Site Number - 3005

Lublin, Poland, 20-400

Actively Recruiting

106

Site Number - 3008

Lublin, Poland, 20-607

Actively Recruiting

107

Site Number - 3004

Lublin, Poland, 91-495

Actively Recruiting

108

Site Number - 3007

Poznan, Poland, 60-354

Actively Recruiting

109

Site Number - 3001

Warsaw, Poland, 00-0189

Actively Recruiting

110

Site Number - 1058

San Juan, Puerto Rico, 00907

Actively Recruiting

111

Site Number - 1037

San Juan, Puerto Rico, 00921-3313

Withdrawn

112

Site Number - 7104

Badalona, Barcelona, Spain, 08916

Actively Recruiting

113

Site Number - 7109

Barcelona, Spain, 08035

Actively Recruiting

114

Site Number - 7103

Barcelona, Spain, 08036

Actively Recruiting

115

Site Number - 7102

Córdoba, Spain, 14004

Actively Recruiting

116

Site Number - 7106

Granada, Spain, 18014

Actively Recruiting

117

Site Number - 7105

Madrid, Spain, 28006

Actively Recruiting

118

Site Number - 7107

Pamplona, Spain, 31008

Actively Recruiting

119

Site Number - 7108

Pamplona, Spain, 31008

Actively Recruiting

120

Site Number - 7101

Seville, Spain, 41009

Actively Recruiting

121

Site Number - 7013

Birmingham, England, United Kingdom, B15 2TT

Actively Recruiting

122

Site Number - 7012

Bristol, England, United Kingdom, BS10 5NB

Actively Recruiting

123

Site Number - 7011

Coventry, England, United Kingdom, CV2 2DX

Actively Recruiting

124

Site Number - 7007

London, England, United Kingdom, NW1 2PG

Actively Recruiting

125

Site Number - 7014

Cambridge, London, United Kingdom, CB2 0QQ

Actively Recruiting

126

Site Number - 7002

Cardiff, United Kingdom, CF14 4XW

Actively Recruiting

127

Site Number - 7008

Edinburgh, United Kingdom, EH16 4SA

Actively Recruiting

128

Site Number - 7005

Huddersfield, United Kingdom, HD3 3EA

Actively Recruiting

129

Site Number - 7004

Hull, United Kingdom, HU6 7RX

Actively Recruiting

130

Site Number - 7003

London, United Kingdom, SE5 9RS

Actively Recruiting

131

Site Number - 7006

Manchester, United Kingdom, M20 4BX

Actively Recruiting

132

Site Number - 7001

Newcastle upon Tyne, United Kingdom, NE1 4LP

Actively Recruiting

133

Site Number - 7009

Norwich, United Kingdom, NR4 7UY

Actively Recruiting

134

Site Number - 7010

Nuneaton, United Kingdom, CV10 7DJ

Actively Recruiting

Loading map...

Research Team

C

Central Study Contact

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Similar Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Stu...

Graves' Disease

Actively Recruiting

145 locations

An Open-label Phase 2 Study to Investigate the Efficacy and ...

Graves' Disease

Actively Recruiting

13 locations

The Safety and Efficacy of Allogenic Anti-CD19/BCMA CAR-T Ce...

Graves' Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here